The Discounted Cash Flow (DCF) valuation of Torii Pharmaceutical Co Ltd (4551.T) is 5,568.75 JPY. With the latest stock price at 6,320.00 JPY, the upside of Torii Pharmaceutical Co Ltd based on DCF is -11.9%.

Is 4551.T a buy or a sell?

Based on the latest price of 6,320.00 JPY and our DCF valuation, Torii Pharmaceutical Co Ltd (4551.T) is a sell. Selling 4551.T stocks now will result in a potential gain of 11.9%.

	Range	Selected
WACC / Discount Rate	5.1% - 7.2%	6.1%
Long-term Growth Rate	2.0% - 4.0%	3.0%
Fair Price	3,480.73 - 15,819.42	5,568.75
Upside	-44.9% - 150.3%	-11.9%

6,320.00 JPY

Stock Price

5,568.75 JPY

Fair Price

REVENUE & EXPENSES

CAPEX

D&A

WORKING CAPITAL

TERMINAL VALUE

4551.T DCF Valuation: Revenue & Expenses Forecast

(JPY in millions)		Projections

	12-2024	12-2025	12-2026	12-2027	12-2028	12-2029

Revenue	60,426	68,214	72,911	79,916	88,665	96,317
% Growth	11%	13%	7%	10%	11%	9%

Cost of goods sold	(33,719)	(37,303)	(39,075)	(41,972)	(45,636)	(48,583)
% of Revenue	56%	55%	54%	53%	51%	50%

Selling, G&A expenses	(16,882)	(19,058)	(20,370)	(22,327)	(24,771)	(26,909)
% of Revenue	28%	28%	28%	28%	28%	28%

Research & Development	(2,824)	(3,188)	(3,407)	(3,735)	(4,144)	(4,501)
% of Revenue	5%	5%	5%	5%	5%	5%

Net interest & other expenses	(276)	(312)	(333)	(365)	(405)	(440)
% of Revenue	0%	0%	0%	0%	0%	0%

Tax expense	(1,682)	(2,200)	(2,561)	(3,033)	(3,610)	(4,183)
Tax rate	25%	26%	26%	26%	26%	26%

Net profit	5,043	6,153	7,164	8,484	10,098	11,700
% Margin	8%	9%	10%	11%	11%	12%